van Noort Baudine C, Keunen Jan E E, Schlingemann Reinier O, Marinkovic Marina
Department of Ophthalmology, Leiden University Medical Centre, Leiden, The Netherlands.
Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Ocul Oncol Pathol. 2019 Jan;5(1):75-78. doi: 10.1159/000488454. Epub 2018 Jun 19.
To report a patient with bilateral diffuse uveal melanocytic proliferation (BDUMP) due to a lung carcinoma, who survived 9.5 years with preservation of good visual acuity after cataract surgery and curative chemotherapy with neoadjuvant radiation therapy.
Clinical review of a patient with BDUMP.
We report the case of a 64-year-old man presenting with bilateral visual deterioration. Ophthalmological examination showed bilateral cataract, a small elevated non-pigmented tumor in the iris and multiple elevated, diffuse round pigmented choroidal lesions. Based on the clinical presentation, the diagnosis of BDUMP was suspected. After referral to an internal medicine specialist, a poorly differentiated non-small cell lung carcinoma was diagnosed and treated with chemotherapy followed by irradiation. After 3 years, spontaneous depigmentation of the choroidal lesions occurred. According to the literature, the mean survival of patients with BDUMP is 11.6 months. Our patient, however, survived for 9.5 years with preservation of good visual acuity after cataract extraction.
This case illustrates that prolonged survival and preservation of useful visual acuity is possible in BDUMP. Cataract surgery should be considered in selected patients, and depigmentation of the lesions may occur during long-term follow-up.
报告一例因肺癌导致双侧弥漫性葡萄膜黑素细胞增生(BDUMP)的患者,该患者在接受白内障手术及新辅助放疗的根治性化疗后存活9.5年,且视力良好。
对一名BDUMP患者进行临床回顾。
我们报告了一名64岁男性患者,其出现双侧视力下降。眼科检查显示双侧白内障、虹膜上一个小的隆起的无色素肿瘤以及多个隆起的、弥漫性圆形色素性脉络膜病变。根据临床表现,怀疑为BDUMP。转诊至内科专家后,诊断为低分化非小细胞肺癌,并接受化疗,随后进行放疗。3年后,脉络膜病变出现自发色素脱失。根据文献,BDUMP患者的平均生存期为11.6个月。然而,我们的患者在白内障摘除术后存活了9.5年,且视力良好。
该病例表明,BDUMP患者有可能实现长期存活并保留有用视力。对于部分患者应考虑进行白内障手术,且在长期随访过程中病变可能会出现色素脱失。